Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a Pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: a retrospective study with 494 patients
Keyword(s):
2011 ◽
Vol 60
(5)
◽
pp. 631-638
◽
2020 ◽
Vol 11
(3)
◽
pp. 3988-3992
Keyword(s):
Keyword(s):